注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
NanoVibronix Inc是一家医疗器械公司。该公司致力于开发利用其低强度表面声波(SAW)技术的无创生物反应激活设备,该技术以生物膜预防、疼痛治疗和伤口愈合为目标,可在家中进行,无需医疗专业人员的协助。该公司的主要产品包括UroShield,PainShield和WoundShield,处于临床和市场发展的不同阶段。UroShield是一种基于超声波的产品,可防止导尿管中的细菌定植和生物膜。PainShield是一种基于贴片的治疗性超声波技术,用于治疗疼痛、肌肉痉挛和关节挛缩。PainShield系列产品包括PainShield MD、PainShield Plus和PainShield Relief。WoundShield是一种基于贴片的治疗性超声波设备,旨在促进组织再生和伤口愈合。该公司的全资子公司为NanoVibronix Ltd。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Yechezkiel Caine | - | - | Member of Medical Advisory Board |
Mitchell J. Schwaber | - | - | Member of Medical Advisory Board |
Shalom Z. Hirschman | 88 | - | Member of Medical Advisory Board |
Samuel Pinchas | - | - | Member of Medical Advisory Board |
Harold Jacob | 70 | 2003 | Chief Medical Officer & Director |
Nathan Keller | - | - | Member of Medical Advisory Board |
Dennis George Maki | - | - | Member of Medical Advisory Board |
Phillip Hanno | - | - | Member of Medical Advisory Board |
Thomas R. Mika | 71 | 2015 | Independent Director |
Christopher M. Fashek | 74 | 2016 | Independent Chairman of the Board |
Brian M. Murphy | 67 | 2016 | CEO & Director |
Michael A. Ferguson | 53 | 2015 | Independent Director |
Martin M. Goldstein | 55 | 2015 | Independent Director |
Maria Schroeder | 65 | 2022 | Independent Director |
Aurora Cassirer | 72 | 2022 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核